Rare diseases
Investigational molecules
Locations
Back to Denmark1 426 clinical trials in Herlev, Denmark across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in DenmarkKliniske-Forsoeg.dk(opens in a new tab)Study of ultevursen treatment in patients with retinitis pigmentosa caused by mutations in USH2A gene exon 13
DenmarkStudy comparing venglustat tablets with standard therapy for adult patients with Fabry disease and left ventricular hypertrophy
DenmarkStudy of cagrilintide and semaglutide combination versus placebo in people with type 2 diabetes and painful diabetic peripheral neuropathy
DenmarkLong-term study of dabrafenib and trametinib in children and adolescents with cancers that have V600 mutation
DenmarkStudy of efavaleukin alfa safety and effectiveness in adults with moderate to severe ulcerative colitis
DenmarkStudy of Efavaleukin Alfa to Treat Adults with Moderate to Severe Ulcerative Colitis
DenmarkStudy of datopotamab deruxtecan with or without durvalumab compared to standard treatment for patients with Stage I-III triple-negative breast cancer who have remaining cancer after initial therapy
DenmarkStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
DenmarkStudy of tarlatamab with durvalumab, carboplatin and etoposide versus standard treatment in patients with previously untreated extensive stage small cell lung cancer
DenmarkLong-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
DenmarkStudy of perineural incobotulinumtoxinA treatment for patients with Complex Regional Pain Syndrome type I or II affecting one side of the body
DenmarkStudy of zorevunersen to reduce seizures in patients with Dravet syndrome
FranceThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on advanced cancer treatments, particularly in endometrial, prostate, and bladder cancers. Studies are evaluating novel combination therapies and immunological approaches.
Research aims to improve treatment outcomes and survival rates through targeted therapeutic approaches.
Comprehensive research into heart failure prevention and treatment of metabolic conditions, including studies on innovative drug combinations and biomarker-targeted approaches.
Focus on developing preventive strategies and improving patient outcomes in cardiovascular conditions.
Studies examining vaccine effectiveness and preventive treatments, particularly in meningococcal and varicella infections. Research includes both pediatric and adult populations.
Emphasis on developing safe and effective preventive measures for infectious diseases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
